SynbiCITE, the UK’s pioneering national Innovation and Knowledge Centre for synthetic biology announced the opening of the country’s first commercial synthetic biology foundry at Imperial College London. SynbiCITE’s Foundry provides automated end-to-end design, construction and validation of synthetic biologic components combined with a unique open-access and sharing software which allows researchers to speed-up innovation by sharing their biodesign protocols with different labs around the world.
You can see the Foundry in action in this report from Sky News.
Do you have a video you would like the sector to see? Contact us.